Tennessee SB 2095: Controlled Substances - As enacted, authorizes a nurse practitioner or physician assistant who holds a federal DEA waiver to prescribe buprenorphine products under certain conditions. - Amends TCA Title 53.

Status: Effective date(s) 05/21/2018 (as of 2018-05-23)

State: Tennessee · Session: 110 · Bill: SB 2095

Subjects: Controlled Substances

Sponsors: Dickerson, Favors

View Tennessee SB 2095 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.